NCT05238376View on ClinicalTrials.gov

Survivorship Post-HCT Optimization Program

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 2, 2022

Primary Completion Date

February 26, 2025

Study Completion Date

March 23, 2025

Conditions
Hematologic Malignancy
Interventions
BEHAVIORAL

Exercise training

12 weeks of high intensity interval training (HIIT) (3x/week) and resistance training (2x/week)

Trial Locations (1)

27705

Duke Adult Blood and Marrow Transplant Clinic, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER

NCT05238376 - Survivorship Post-HCT Optimization Program | Biotech Hunter | Biotech Hunter